HCMT
PBYI icon

Highland Capital Management (Texas)’s Puma Biotechnology PBYI Stock Holding History

Highland Capital Management (Texas)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,500
Closed -$642K – 357
2017
Q4 		$642K Buy
+6,500
New +$727K 0.03% 192

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Highland Capital Management (Texas)'s PBYI Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of Puma Biotechnology (PBYI) in Q4 2017, closing a stake of 15,987 shares — an estimated $1.79M sold.

Highland Capital Management (Texas) first reported a position in PBYI in Q4 2016 and held it in 3 quarters. The position peaked at $1.92M in Q3 2017. 203 funds tracked by Wall St. Rank hold PBYI as of Q4 2017.

  • Highland Capital Management (Texas) reported no remaining Puma Biotechnology position as of Q4 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 15,987 Puma Biotechnology shares in Q4 2017, an estimated $1.79M.
  • Highland Capital Management (Texas) first reported a position in Puma Biotechnology in Q4 2016 and held it in 3 quarters.
  • Highland Capital Management (Texas)'s Puma Biotechnology position peaked at $1.92M in Q3 2017.
  • 203 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.